Skip to main content

Advertisement

Log in

Is Lipidomic the Answer to the Search of a Biomarker for Organ Preservation Protocol in Head and Neck Squamous Cell Carcinoma?

  • Short Communication
  • Published:
Pathology & Oncology Research

Abstract

In the last decade organ preservation protocols based on chemoradiotherapy (CRT) has been showing the possibility of preserving function without jeopardizing survival for locally advanced head and neck squamous cell carcinoma (HNSCC). Still, only a percentage of the patients will benefit from this approach and, to date, no biomarkers are known to correctly predict these patients. More recently, modern mass spectrometry method has been used to determine metabolic profiles, and lipidomics, in particular, emerged as a new field of study in oncology and other diseases. This study aimed to analyze the lipid profile on saliva from patients undergoing to a prospective, single center, open-label, non-randomized phase II trial for organ preservation on HNSCC. The lipid analysis was performed using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS). Multivariate statistical analyses based on principal component analysis and orthogonal partial least square-discriminant analysis were applied to MALDI-TOF-MS data to visualize differences between the lipid profiles and identify potential biomarkers. The results assisted on distinguishing complete responders from non-responders to the treatment protocol. In conclusion, we demonstrated that a group of lipids is differentially abundant in saliva from HNSCC patients submitted to an organ preservation protocol, being able to differentiate responders from non-responders. These results suggest the potential use of lipid biomarkers to identify patients who may benefit from this treatment. Also, we showed that saliva testing might be routinely used in clinical practice, for being a non-invasive alternative to blood testing, besides inexpensive and easy to obtain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371(9625):1695–1709

    Article  PubMed  CAS  Google Scholar 

  2. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37(8):911–917

    Article  PubMed  CAS  Google Scholar 

  3. Denaro N, Russi EG, Adamo V, Merlano MC (2014) State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. Oncology 86(4):212–229

    Article  PubMed  CAS  Google Scholar 

  4. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11):1143–1154

    Article  PubMed  CAS  Google Scholar 

  5. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9(2):139–150

    Article  PubMed  CAS  Google Scholar 

  6. Hilvo M, Gade S, Hyotylainen T, Nekljudova V, Seppanen-Laakso T, Sysi-Aho M et al (2014) Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer 134(7):1725–1733

    Article  PubMed  CAS  Google Scholar 

  7. Holsinger FC, Lin HY, Bassot V, Laccourreye O (2009) Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx. Cancer 115(17):3909–3918

    Article  PubMed  CAS  Google Scholar 

  8. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88(13):890–899

    Article  PubMed  CAS  Google Scholar 

  9. Li X, Yuan YJ (2011) Lipidomic analysis of apoptotic hela cells induced by Paclitaxel. Omics: J Integr Biol 15(10):655–664

    Article  CAS  Google Scholar 

  10. Li G, Da M, Zhang W, Wu H, Ye J, Chen J et al (2016) Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 45(3):167–172

    Article  CAS  Google Scholar 

  11. Marur S, D'Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11(8):781–789

    Article  PubMed  PubMed Central  Google Scholar 

  12. Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 92(1):4–14

    Article  Google Scholar 

  13. Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA et al (2011) Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C(1)(8)-ceramide as a novel biomarker for monitoring response. Clinical cancer research: an official journal of the American Association for Cancer Research 17(18):6097–6105

    Article  CAS  Google Scholar 

  14. de Souza Viana L, de Aguiar Silva FC, Andrade Dos Anjos Jacome A, Calheiros Campelo Maia D, Duarte de Mattos M, Arthur Jacinto A et al (2016) Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma. Head Neck 38(1):E970–E980

    Article  PubMed  Google Scholar 

  15. Stegemann C, Drozdov I, Shalhoub J, Humphries J, Ladroue C, Didangelos A et al (2011) Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet 4(3):232–242

    Article  PubMed  CAS  Google Scholar 

  16. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

    Article  PubMed  Google Scholar 

  17. Wang Q, Gao P, Wang X, Duan Y (2014) The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci Rep 4:6802

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Wood PL (2012) Lipidomics of Alzheimer's disease: current status. Alzheimers Res Ther 4(1):5

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Zhao C, Mao J, Ai J, Shenwu M, Shi T, Zhang D et al (2013) Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus. BMC Med Genet 6(1):S12

    Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the Barretos Cancer Hospital and the Urology Discipline at Federal University of Sao Paulo - Sao Paulo, Brazil for the financial support of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Carolina Laus.

Ethics declarations

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflicts of Interest Statement

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laus, A.C., da Silva, I.D.C.G., Cordeiro, F.B. et al. Is Lipidomic the Answer to the Search of a Biomarker for Organ Preservation Protocol in Head and Neck Squamous Cell Carcinoma?. Pathol. Oncol. Res. 24, 931–935 (2018). https://doi.org/10.1007/s12253-017-0336-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-017-0336-x

Keywords

Navigation